For other functions strategic marketing of the national diabetes prevention program to priority populations
Ended Awarded Last action
- Contract number
- 75D30118F02078
- Awardee
-
ICF Macro Inc. UEI DQ7YZMCK5D23 Part of ICF International, Inc.
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,855,175
Award facts
- Opportunity
-
- 75D30118Q68502 Solicitation number
- Contract value 99% obligated
-
- $1,855,175.07 Current, with exercised options
- $1,879,930.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541613 Marketing Consulting Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fairfax, VA 22031, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$24,755 | |
| Exercise an Option | $490,310 | |
| Exercise an Option | $476,593 | |
| Exercise an Option | $463,257 | |
| Original award | $449,770 |
About this award
The Centers for Disease Control and Prevention (CDC) awarded a $1.88 million firm fixed-price BPA (Blanket Purchase Agreement) call to ICF Macro Inc. on September 24, 2018, for strategic marketing of the National Diabetes Prevention Program to priority populations. The contract, which was performed in Fairfax, VA, and ultimately completed on September 23, 2022, was issued without a set-aside designation under the Health Marketing Services BPA. ICF Macro Inc., a subsidiary of ICF International, Inc., leveraged its extensive expertise in health communications campaigns and behavioral health marketing to support CDC's efforts to reach underserved communities with diabetes prevention initiatives.
ICF Macro is well-positioned to execute this work given its proven track record delivering health communications and marketing services across multiple CDC contracts and its demonstrated capability in survey research, data collection, program evaluation, and technical assistance. The company's experience supporting public health campaigns, combined with its access to significant CDC-held IDVs such as the SHEPheRD program ($99 million potential value), reflects its established relationship with the agency. This diabetes prevention program marketing contract represents a focused engagement to expand awareness and uptake of evidence-based prevention services among high-risk and underrepresented populations.
Quick answers
Who was awarded contract 75D30118F02078?
75D30118F02078 was awarded to ICF Macro Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 24, 2018.
How much is contract 75D30118F02078 worth?
The government has obligated $1,855,175 on 75D30118F02078. Its potential value, with all options, is $1,879,930.
Is contract 75D30118F02078 an order under another contract?
Yes. 75D30118F02078 is a BPA call under HHSD2002015M88159B, a blanket purchase agreement, on Health Marketing Services BPA.
Was contract 75D30118F02078 competed?
The extent of competition for 75D30118F02078 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award